Dissecting the dynamics of dysregulation of cellular processes in mouse mammary gland tumor

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Mentzen, Wieslawa I ^a   Floris, Matteo ^a   de la Fuente, Alberto ^a  

^a Parco Scientifico e Technologico POLARIS ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MICRORNA; TRANSCRIPTOME;

ANALYTIC METHOD; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CELL ADHESION; CELL FUNCTION; CELL METABOLISM; DISEASE COURSE; DOWN REGULATION; GENE ASSIGNMENT; GENE EXPRESSION; GENE IDENTIFICATION; GENE INACTIVATION; IMMUNE SYSTEM; MOUSE; NONHUMAN; PROTEIN INTERACTION; UPREGULATION; ANIMAL; BIOMETRY; CELL TRANSFORMATION; CHEMISTRY; DNA MICROARRAY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METHODOLOGY; PATHOLOGY;

ANIMALS; BIOMETRY; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 74049143935     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-601     Document Type: Article

References (59)

1. Bertucci F, Birnbaum D. Reasons for breast cancer heterogeneity. J Biol 2008, 7(2):6. 10.1186/jbiol67, 2263121, 18304379.
2. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001, 2:343-372. 10.1146/annurev.genom.2.1.343, 11701654.
3. Sauer U, Heinemann M, Zamboni M. GENETICS: Getting closer to the whole picture. Science 2007, 316(5824):550-551. 10.1126/science.1142502, 17463274.
4. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature 1999, 402:C47-C52. 10.1038/35011540, 10591225.
5. Rives AW, Galitski T. Modular organization of cellular networks. Proc Natl Acad Sci USA 2003, 100:1128-1133. 10.1073/pnas.0237338100, 298738, 12538875.
6. Marcotte E, Pellegrini M, Ng H, Rice D, Yeates T, Eisenberg D. Detecting protein function and protein-protein interactions from genome sequences. Science 1999, 285(5428):751-753. 10.1126/science.285.5428.751, 10427000.
7. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000, 403(6770):623-627. 10.1038/35001009, 10688190.
8. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, Vidalain PO, Han JD, Chesneau A, Hao T, et al. A map of the interactome network of the metazoan C. elegans. Science 2004, 303(5657):540-543. 10.1126/science.1091403, 1698949, 14704431.
9. Cairns J. Mutation selection and the natural history of cancer. Nature 1975, 255:197-200. 10.1038/255197a0, 1143315.
10. Choi JK, Yu U, Yoo OJ, Kim S. Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics 2005, 21(24):4348-4355. 10.1093/bioinformatics/bti722, 16234317.
11. Xu M, Kao M-CJ, Nunez-Iglesias J, Nevins JR, West M, Zhou XJ. An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics 2008, 9(Suppl 1):S12. 10.1186/1471-2164-9-S1-S12, 2386054, 18366601.
12. Chuang H-Y, Lee E, Liu Y-T, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Molecular Systems Biology 2007, 3:140. 10.1038/msb4100180, 2063581, 17940530.
13. Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, Dalla-Favera R, Califano A. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol Syst Biol 2008, 4:169. 10.1038/msb.2008.2, 2267731, 18277385.
14. Li Z, Tognon C, Godinho F, Yasaitis L, Hock H, Herschkowitz J, Lannon C, Cho E, Kim S, Bronson R, et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007, 12:542-558. 10.1016/j.ccr.2007.11.012, 2175032, 18068631.
15. Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 2000, 19:906-915. 10.1038/sj.onc.1203396, 10702799.
16. Liu Q, Schwaller J, Kutok J, Cain D, Aster JC, Williams IR, Gilliland DG. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBOJ 2000, 19:1827-1838.
17. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002, 2(5):367-376. 10.1016/S1535-6108(02)00180-0, 12450792.
18. Di Leva G, Calin GA, Croce CM. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today 2006, 78(2):180-189. 10.1002/bdrc.20073, 16847883.
19. Wiemer EAC. The role of microRNAs in cancer: No small matter. European Journal of Cancer 2007, 43(10):1529-1544. 10.1016/j.ejca.2007.04.002, 17531469.
20. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6(11):857-866. 10.1038/nrc1997, 17060945.
21. Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006, 16(1):4-9. 10.1016/j.gde.2005.12.005, 16361094.
22. Xia K, Dong D, Han JD. IntNetDB v1.0: an integrated protein-protein interaction network database generated by a probabilistic model. BMC Bioinformatics 2006, 7:508. 10.1186/1471-2105-7-508, 1661597, 17112386.
23. van Dongen S. Graph clustering by flow simulation. PhD thesis 2000, University of Utrecht.
24. Brohée S, van Helden J. Evaluation of clustering algorithms for protein-protein interaction networks. BMC Bioinformatics 2006, 7(488).
25. Steuer R, Humburg P, Selbig J. Validation and functional annotation of expression-based clusters based on gene ontology. BMC Bioinformatics 2006, 7:380. 10.1186/1471-2105-7-380, 1586215, 16911788.
26. DAVID Bioinformatics Resources. , http://david.abcc.ncifcrf.gov/
27. Dennis G, Sherman B, Hosack D, Yang J, Gao W, Lane H, Lempicki R. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
28. Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M, Paulovich A, Pomeroy S, Golub T, Lander E, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896,1239896, 16199517.
29. Dinu I, Potter JD, Mueller T, Liu Q, Adewale A, Jhangri G, Einecke G, Famulski K, Halloran P, Yasui Y. Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics 2007, 8:242. 10.1186/1471-2105-8-242, 1931607, 17612399.
30. Hosack DA, Dennis GJ, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4(R70).
31. Molecular Signatures Database. , http://www.broad.mit.edu/gsea/msigdb/index.jsp
32. Hanahan D, Weinberg R. The hallmarks of cancer. Cell 2000, 100(1):57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
33. Varner JA, Cheresh DA. Integrins and cancer. Current Opinion in Cell Biology 1996, 8(5):724-730. 10.1016/S0955-0674(96)80115-3, 8939661.
34. Weinberg RA. The biology of cancer. 2007, New York: Garland Science.
35. Chen L, Mizuno MT, Singhal MC, Hu HSL, Galloway DA, Hellstrom I, Hellstrom KE. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol 1992, 148:2617-2621.
36. Chen LP, Thomas EK, Hu HSL, Hellstrom I, Hellstrom KE. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA 1991, 88:110-114. 10.1073/pnas.88.1.110, 50759, 1846033.
37. Watson M. CoXpress: differential co-expression in gene expression data. BMC Bioinformatics 2006, 7:509. 10.1186/1471-2105-7-509, 1660556, 17116249.
38. Metcalf D. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia 1989, 3:270-276.
39. Marusić A, Kalinowski JF, Jastrzebski S, Lorenzo JA. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J Bone Mineral Res 1993, 8:617-624.
40. Crichton MB, Nichols JE, Zhao Y, Bulun SE, Simpson ER. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Endocrinol 1996, 118:215-220.
41. Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine & Growth Factor Reviews 2004, 15(6):419-433. 10.1016/j.cytogfr.2004.09.002, 15561600.
42. Pardoll D. Does the immune system see tumors as foreign or self?. Annual Review of Immunology 2003, 21:807-839. 10.1146/annurev.immunol.21.120601.141135, 12615893.
43. Kilian J, Whitehead D, Horak J, Wanke D, Weinl S, Batistic O, D'Angelo C, Bornberg-Bauer E, Kudla J, Harter K. The AtGenExpress global stress expression data set: protocols, evaluation and model data analysis of UV-B light, drought and cold stress responses. Plant Journal 2007, 50:347-363. 10.1111/j.1365-313X.2007.03052.x, 17376166.
44. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 36 (Database issue) 2002, 30(1):207-210.
45. Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529. 10.1073/pnas.242606799, 137750, 12434020.
46. Sassen S, Miska E, Caldas C. MicroRNA: implications for cancer. Virchows Arch 2008, 452(1):1-10. 10.1007/s00428-007-0532-2, 2151131, 18040713.
47. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67(18):8699-8707. 10.1158/0008-5472.CAN-07-1936, 17875710.
48. Bracken C, Gregory P, Kolesnikoff N, Bert A, Wang J, Shannon M, Goodall G. A double-negative feedback loop between ZEB1-SIP1 and the m icroRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68(19):7846-7854. 10.1158/0008-5472.CAN-08-1942, 18829540.
49. Tryndyak VP, Ross SA, Beland FA, Pogribny IP. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 2009, 48(6):479-487. 10.1002/mc.20484, 18942116.
50. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C. Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis. World J Surg 2009, 33(4):698-709. 10.1007/s00268-008-9833-0, 19030927.
51. Cui XY, Guo YJ, Yao HR. [Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR]. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University] 2008, 28(10):1813-1815.
52. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003, 15:740-746. 10.1016/j.ceb.2003.10.006, 14644200.
53. Mentzen WI, Wurtele ES. Regulon organization of Arabidopsis. BMC Plant Biology 2008, 8:99. 10.1186/1471-2229-8-99, 2567982, 18826618.
54. Mouse Genome Informatics. , http://www.informatics.jax.org/
55. Bult C, Eppig J, Kadin J, Richardson J, Blake J, . the members of the Mouse Genome Database Group The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Res 36 (Database issue) 2008, D724:8. the members of the Mouse Genome Database Group.
56. R Development Core Team R: A language and environment for statistical computing. 2004, R Foundation for Statistical Computing. Vienna, Austria, R Development Core Team.
57. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: Tools for microRNA genomics. Nucleic Acids Research (Database Issue) 2008, 36:D154-D158.
58. BioMart Project. , http://www.ensembl.org/biomart/index.html
59. Batagelj V, Mrvar A. Pajek - Program for Large Network Analysis. Connections 1998, 21:47-57.